MMV371 / J&J, Medicines for Malaria Venture - LARVOL DELTA

MV371 LAI FiH: Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV371 LAI in Healthy Participants (clinicaltrials.gov) - P1 | N=24 | Completed | Sponsor: Medicines for Malaria Venture | Recruiting ➔ Completed

First-in-human • Trial completion • Infectious Disease • Malaria

Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of LAI MMV055 Alone and in Combination With MMV371 in Healthy Participants (clinicaltrials.gov) - P1 | N=72 | Recruiting | Sponsor: Medicines for Malaria Venture | Not yet recruiting ➔ Recruiting

Enrollment open • Infectious Disease • Malaria

Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of LAI MMV055 Alone and in Combination With MMV371 in Healthy Participants (clinicaltrials.gov) - P1 | N=72 | Not yet recruiting | Sponsor: Medicines for Malaria Venture

New P1 trial • Infectious Disease • Malaria

MV371 LAI FiH: Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV371 LAI in Healthy Participants (clinicaltrials.gov) - P1 | N=24 | Recruiting | Sponsor: Medicines for Malaria Venture | Trial completion date: Mar 2025 ➔ Aug 2025 | Trial primary completion date: Mar 2025 ➔ Aug 2025

Trial completion date • Trial primary completion date • Infectious Disease • Malaria

MV371 LAI FiH: Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV371 LAI in Healthy Participants (clinicaltrials.gov) - P1 | N=24 | Recruiting | Sponsor: Medicines for Malaria Venture | Not yet recruiting ➔ Recruiting

Enrollment open • Infectious Disease • Malaria

MV371 LAI FiH: Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV371 LAI in Healthy Participants (clinicaltrials.gov) - P1 | N=24 | Not yet recruiting | Sponsor: Medicines for Malaria Venture

New P1 trial • Infectious Disease • Malaria